NYSEARCA:IDNA iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News $22.97 +0.43 (+1.91%) Closing price 08/22/2025 04:10 PM EasternExtended Trading$22.99 +0.02 (+0.09%) As of 06:54 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IDNA alerts:Sign Up Key Stats Today's Range$22.70▼$23.2050-Day Range$20.39▼$22.9752-Week Range$17.26▼$25.80Volume19,809 shsAverage Volume29,904 shsMarket Capitalization$118.30 millionAssets Under Management$114.60 millionDividend Yield1.13%Net Expense Ratio0.47%Aggregate RatingModerate Buy ETF Overview The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock. Read More iShares Genomics Immunology and Healthcare ETF ExpensesTypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.56%0.51%0.53%Other Expenses0.00%0.57%0.56%0.59%0.56%Total Expense0.47%0.74%0.76%0.74%0.73%Fee Waiver0.00%-0.76%-0.66%-0.71%-0.63%Net Expense0.47%0.60%0.63%0.58%0.60% Receive IDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IDNA ETF News HeadlinesIDNA: The Cutting Edge Of Medical Science Is A Risky InvestmentApril 20, 2025 | seekingalpha.comIshares Healthcare Innov Ucits Etf Acc Share Price (HEAL.MI)November 7, 2024 | lse.co.ukBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.August 25 at 2:00 AM | Goldco Precious Metals (Ad)iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IUHC.L)September 25, 2024 | finance.yahoo.comiDNA Genomics Public LtdMay 18, 2024 | morningstar.comMiShares Genomics Immunology and Healthcare ETF (IDNA)April 15, 2024 | finance.yahoo.comSee More Headlines IDNA ETF - Frequently Asked Questions How have IDNA shares performed this year? iShares Genomics Immunology and Healthcare ETF's stock was trading at $22.63 at the beginning of 2025. Since then, IDNA stock has increased by 1.5% and is now trading at $22.97. Who are iShares Genomics Immunology and Healthcare ETF's major shareholders? iShares Genomics Immunology and Healthcare ETF's top institutional shareholders include Portland Global Advisors LLC (1.99%), Ameriprise Financial Inc. (1.28%) and Flow Traders U.S. LLC (0.88%). How do I buy shares of iShares Genomics Immunology and Healthcare ETF? Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Genomics Immunology and Healthcare ETF investors own include iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), AU Optronics (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Fund Details IssueriShares Fund NameiShares Genomics Immunology and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IDNA Inception Date6/11/2019 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings56 Fund Statistics Assets Under Management$114.60 million Average Daily Volume$0.00 Discount/Premium0.05% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableOptionable Options Volume4 Put Options1 Call Options4 Short Interest2,400 shs Miscellaneous Outstanding Shares5,150,000Beta0.90 Creation Unit50,000 Creation Fee$850.00 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report Top 10 IDNA HoldingsBeOne Medicines Ltd.Holding Weight: 4.81%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 4.58%Incyte (NASDAQ:INCY)Holding Weight: 4.51%Moderna (NASDAQ:MRNA)Holding Weight: 4.46%Twist Bioscience (NASDAQ:TWST)Holding Weight: 4.40%Arcellx (NASDAQ:ACLX)Holding Weight: 4.34%AstraZeneca PLCHolding Weight: 4.25%Genmab A/SHolding Weight: 4.14%BioNTech (NASDAQ:BNTX)Holding Weight: 4.10%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 4.10%Full Holdings DetailsIDNA Sector ExposureIDNA Industry Exposure This page (NYSEARCA:IDNA) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access